Sanjana Vitta
Optometrist · Charleston, SCNPI 1497486534
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $1,890 of the $2,856 with a category attached, or 66.2%. Alcon accounts for 67.6% of it on its own, with 5 other manufacturers making up the rest. Reporting peaked in 2024 at $2,129 and has fallen 96.9% since, to $65 in 2025.
Across 33 payments — averaging $86.53 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Alcon$2K
- Coopervision Inc.$511
- Astellas Pharma US Inc$167
- Glaukos Corporation$137
- Dompe US, Inc.$86
- Tarsus Pharmaceuticals, Inc.$25
What the payments were for
- Travel & lodging$96534%
- Food & beverage$1,89066%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Alcon | 18 | $1,931 |
| Coopervision Inc. | 11 | $511 |
| Astellas Pharma US Inc | 1 | $167 |
| Glaukos Corporation | 1 | $137 |
| Dompe US, Inc. | 1 | $86 |
| Tarsus Pharmaceuticals, Inc. | 1 | $25 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,856 in reported general payments places this provider in the 80th percentile of 653 optometrist providers in South Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| RestasisCyclosporine | 14 | $9,951 |
| Latanoprost | 55 | $298 |
Paid to pharmacies, not to this prescriber.
Other optometrist in Charleston
- Richard BedellCharleston$55K
- Jennifer ZolmanCharleston$21K
- Michael ZolmanCharleston$14K
- Chad CarlssonCharleston$13K
- Michele DonovanCharleston$7K
- William DentonCharleston$7K
- Elyse DewittCharleston$6K
- Jensen RafoolCharleston$6K
- Alexa RoweCharleston$6K
- Thomas WeshefskyMyrtle Beach$77K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.